Advances in cryopreservation of stallion semen in modified INRA82.

In the procedure used in this paper, semen was first diluted in INRA82+2% egg yolk (E1) at 37 degrees C. Before or after cooling to 4 degrees C, semen was centrifuged and diluted in E1+2.5% glycerol (E2). Cooled semen was frozen in 0.5-ml straws. Straws were thawed at 37 degrees C for 30s. For fertility trials, frozen ejaculates were used only if total post-thaw motility was above 35%. Most mares were inseminated two times before ovulation with 400 x 10(6) total spermatozoa every 24h. This paper presents post-thaw motility (CASA) and fertility results obtained when some steps of the procedure were evaluated.Use of the first three jets of ejaculate before the centrifugation did not improve post-thaw motility compared to use of the whole semen (25% versus 25%, 2 stallions x 12 ejaculates, P>0.80). When the first dilution was performed in E2 at 22 degrees C instead of in E1 at 37 degrees C, motility was slightly improved (38% versus 36%, n>283 ejaculates per group, P<0.04) but fertility was similar (51% versus 58%, n>196 cycles per group, P>0.10). Coating the spermatozoa with 0.5, 1, 2, 4 and 8mM of Concanavalin A resulted in unchanged post-thaw motility (6 stallions x 3 ejaculates, P>0.05). The extender E2 was modified or supplemented with different substances. Increasing egg yolk concentration from 2 to 4% (v/v) did not increase post-thaw motility (42% versus 34%, 6 stallions x 2 ejaculates, P>0.05). Different glycerol concentrations (range: 1.7-3.7%) had no significant effect on post-thaw motility even though 2.4-2.8% resulted in a nonsignificant higher motility (7 stallions x 2 ejaculates, P>0.05). Glutamine at 50mM in E2 improved post-thaw motility compared with no glutamine (49% versus 46%, n>584 ejaculates per group, P<0.0001) but not fertility (53% versus 54%, n>451 cycles per group, P>0.80). Thawing at 75 degrees C for 10s slightly increased motility after 120 min at 37 degrees C (6 stallions x 1 ejaculate, P<0.05) but no effect on per-cycle fertility was noted (32% (19 cycles) versus 41% (17 cycles), P>0.50). When post-thaw dilution was performed using a fixed molarity multi-step system (25 mOsm per step) from various osmolarities (900-690 mOsm) to 365 mOsm, motility was unaffected compared with dilution in one step (36% versus 38%, 6 stallions x 1 ejaculate, P>0.20).     

TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

Background

TIMI frame count (TFC) predicts outcomes in patients with obstructive coronary artery disease (CAD); it remains unclear whether TFC predicts outcomes in patients without obstructive CAD.

Methods

TFC was determined in a sample of women with no obstructive CAD enrolled in the Women''s Ischemia Syndrome Evaluation (WISE) study. Because TFC is known to be higher in the left anterior descending artery (LAD), TFC determined in the LAD was divided by 1.7 to provide a corrected TFC (cTFC).

Results

A total of 298 women, with angiograms suitable for TFC analysis and long-term (6–10 year) follow up data, were included in this sub-study. Their age was 55±11 years, most were white (86%), half had a history of smoking, and half had a history of hypertension. Higher resting cTFC was associated with a higher rate of hospitalization for angina (34% in women with a cTFC >35, 15% in women with a cTFC ≤35, P<0.001). cTFC provided independent prediction of hospitalization for angina after adjusting for many baseline characteristics. In this cohort, resting cTFC was not predictive of major events (myocardial infarction, heart failure, stroke, or all-cause death), cardiovascular events, all-cause mortality, or cardiovascular mortality.

Conclusions

In women with signs and symptoms of ischemia but no obstructive CAD, resting cTFC provides independent prediction of hospitalization for angina. Larger studies are required to determine if resting TFC is predictive of major events in patients without obstructive coronary artery disease.     

Landscape Factors Facilitating the Invasive Dynamics and Distribution of the Brown Marmorated Stink Bug,Halyomorpha halys (Hemiptera: Pentatomidae), after Arrival in the United States

The brown marmorated stink bug, Halyomorpha halys, a native of Asia, has become a serious invasive pest in the USA. H. halys was first detected in the USA in the mid 1990s, dispersing to over 41 other states. Since 1998, H. halys has spread throughout New Jersey, becoming an important pest of agriculture, and a major nuisance in urban developments. In this study, we used spatial analysis, geostatistics, and Bayesian linear regression to investigate the invasion dynamics and colonization processes of this pest in New Jersey. We present the results of monitoring H. halys from 51 to 71 black light traps that were placed on farms throughout New Jersey from 2004 to 2011 and examined relationships between total yearly densities of H. halys and square hectares of 48 landscape/land use variables derived from urban, wetland, forest, and agriculture metadata, as well as distances to nearest highways. From these analyses we propose the following hypotheses: (1) H. halys density is strongly associated with urban developments and railroads during its initial establishment and dispersal from 2004 to 2006; (2) H. halys overwintering in multiple habitats and feeding on a variety of plants may have reduced the Allee effect, thus facilitating movement into the southernmost regions of the state by railroads from 2005 to 2008; (3) density of H. halys contracted in 2009 possibly from invading wetlands or sampling artifact; (4) subsequent invasion of H. halys from the northwest to the south in 2010 may conform to a stratified-dispersal model marked by rapid long-distance movement, from railroads and wetland rights-of-way; and (5) high densities of H. halys may be associated with agriculture in southern New Jersey in 2011. These landscape features associated with the invasion of H. halys in New Jersey may predict its potential rate of invasion across the USA and worldwide.     

HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania

A national ART program was launched in Tanzania in October 2004. Due to the existence of multiple HIV-1 subtypes and recombinant viruses co-circulating in Tanzania, it is important to monitor rates of drug resistance. The present study determined the prevalence of HIV-1 drug resistance mutations among ART-naive female bar and hotel workers, a high-risk population for HIV-1 infection in Moshi, Tanzania. A partial HIV-1 pol gene was analyzed by single-genome amplification and sequencing in 45 subjects (622 pol sequences total; median number of sequences per subject, 13; IQR 5–20) in samples collected in 2005. The prevalence of HIV-1 subtypes A1, C, and D, and inter-subtype recombinant viruses, was 36%, 29%, 9% and 27%, respectively. Thirteen different recombination patterns included D/A1/D, C/A1, A1/C/A1, A1/U/A1, C/U/A1, C/A1, U/D/U, D/A1/D, A1/C, A1/C, A2/C/A2, CRF10_CD/C/CRF10_CD and CRF35_AD/A1/CRF35_AD. CRF35_AD was identified in Tanzania for the first time. All recombinant viruses in this study were unique, suggesting ongoing recombination processes among circulating HIV-1 variants. The prevalence of multiple infections in this population was 16% (n = 7). Primary HIV-1 drug resistance mutations to RT inhibitors were identified in three (7%) subjects (K65R plus Y181C; N60D; and V106M). In some subjects, polymorphisms were observed at the RT positions 41, 69, 75, 98, 101, 179, 190, and 215. Secondary mutations associated with NNRTIs were observed at the RT positions 90 (7%) and 138 (6%). In the protease gene, three subjects (7%) had M46I/L mutations. All subjects in this study had HIV-1 subtype-specific natural polymorphisms at positions 36, 69, 89 and 93 that are associated with drug resistance in HIV-1 subtype B. These results suggested that HIV-1 drug resistance mutations and natural polymorphisms existed in this population before the initiation of the national ART program. With increasing use of ARV, these results highlight the importance of drug resistance monitoring in Tanzania.     

Comparative Analyses of Three Chlorella Species in Response to Light and Sugar Reveal Distinctive Lipid Accumulation Patterns in the Microalga C. sorokiniana

While photosynthetic microalgae, such as Chlorella, serve as feedstocks for nutritional oils and biofuels, heterotrophic cultivation can augment growth rates, support high cell densities, and increase triacylglycerol (TAG) lipid content. However, these species differ significantly in their photoautotrophic and heterotrophic characteristics. In this study, the phylogeny of thirty Chlorella strains was determined in order to inform bioprospecting efforts and detailed physiological assessment of three species. The growth kinetics and lipid biochemistry of C. protothecoides UTEX 411, C. vulgaris UTEX 265, and C. sorokiniana UTEX 1230 were quantified during photoautotrophy in Bold''s basal medium (BBM) and heterotrophy in BBM supplemented with glucose (10 g L⁻¹). Heterotrophic growth rates of UTEX 411, 265, and 1230 were found to be 1.5-, 3.7-, and 5-fold higher than their respective autotrophic rates. With a rapid nine-hour heterotrophic doubling time, Chlorella sorokiniana UTEX 1230 maximally accumulated 39% total lipids by dry weight during heterotrophy compared to 18% autotrophically. Furthermore, the discrete fatty acid composition of each strain was examined in order to elucidate lipid accumulation patterns under the two trophic conditions. In both modes of growth, UTEX 411 and 265 produced 18∶1 as the principal fatty acid while UTEX 1230 exhibited a 2.5-fold enrichment in 18∶2 relative to 18∶1. Although the total lipid content was highest in UTEX 411 during heterotrophy, UTEX 1230 demonstrated a two-fold increase in its heterotrophic TAG fraction at a rate of 28.9 mg L⁻¹ d⁻¹ to reach 22% of the biomass, corresponding to as much as 90% of its total lipids. Interestingly, UTEX 1230 growth was restricted during mixotrophy and its TAG production rate was suppressed to 18.2 mg L⁻¹ d⁻¹. This constraint on carbon flow raises intriguing questions about the impact of sugar and light on the metabolic regulation of microalgal lipid biosynthesis.     

Bone Marrow-Derived Mesenchymal Stem Cells Drive Lymphangiogenesis

It is now well accepted that multipotent Bone-Marrow Mesenchymal Stem Cells (BM-MSC) contribute to cancer progression through several mechanisms including angiogenesis. However, their involvement during the lymphangiogenic process is poorly described. Using BM-MSC isolated from mice of two different backgrounds, we demonstrate a paracrine lymphangiogenic action of BM-MSC both in vivo and in vitro. Co-injection of BM-MSC and tumor cells in mice increased the in vivo tumor growth and intratumoral lymphatic vessel density. In addition, BM-MSC or their conditioned medium stimulated the recruitment of lymphatic vessels in vivo in an ear sponge assay, and ex vivo in the lymphatic ring assay (LRA). In vitro, MSC conditioned medium also increased the proliferation rate and the migration of both primary lymphatic endothelial cells (LEC) and an immortalized lymphatic endothelial cell line. Mechanistically, these pro-lymphangiogenic effects relied on the secretion of Vascular Endothelial Growth Factor (VEGF)-A by BM-MSC that activates VEGF Receptor (VEGFR)-2 pathway on LEC. Indeed, the trapping of VEGF-A in MSC conditioned medium by soluble VEGF Receptors (sVEGFR)-1, -2 or the inhibition of VEGFR-2 activity by a specific inhibitor (ZM 323881) both decreased LEC proliferation, migration and the phosphorylation of their main downstream target ERK1/2. This study provides direct unprecedented evidence for a paracrine lymphangiogenic action of BM-MSC via the production of VEGF-A which acts on LEC VEGFR-2.     

The prevalence of alpha-1 antitrypsin deficiency in Ireland

Background

High frequency chest wall oscillation (HFCWO) is used for airway mucus clearance. The objective of this study was to evaluate the use of HFCWO early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).

Methods

Randomized, multi-center, double-masked phase II clinical trial of active or sham treatment initiated within 24 hours of hospital admission for acute asthma or COPD at four academic medical centers. Patients received active or sham treatment for 15 minutes three times a day for four treatments. Medical management was standardized across groups. The primary outcomes were patient adherence to therapy after four treatments (minutes used/60 minutes prescribed) and satisfaction. Secondary outcomes included change in Borg dyspnea score (≥ 1 unit indicates a clinically significant change), spontaneously expectorated sputum volume, and forced expired volume in 1 second.

Results

Fifty-two participants were randomized to active (n = 25) or sham (n = 27) treatment. Patient adherence was similarly high in both groups (91% vs. 93%; p = 0.70). Patient satisfaction was also similarly high in both groups. After four treatments, a higher proportion of patients in the active treatment group had a clinically significant improvement in dyspnea (70.8% vs. 42.3%, p = 0.04). There were no significant differences in other secondary outcomes.

Conclusions

HFCWO is well tolerated in adults hospitalized for acute asthma or COPD and significantly improves dyspnea. The high levels of patient satisfaction in both treatment groups justify the need for sham controls when evaluating the use of HFCWO on patient-reported outcomes. Additional studies are needed to more fully evaluate the role of HFCWO in improving in-hospital and post-discharge outcomes in this population.

Trial Registration

ClinicalTrials.gov: NCT00181285     

Reassessing the role of YUCCAs in auxin biosynthesis

It is remarkable that although auxin was the first growth-promoting plant hormone to be discovered, and although more researchers work on this hormone than on any other, we cannot be definitive about the pathways of auxin synthesis in plants. In 2001, there appeared to be a dramatic development in this field, with the announcement of a new gene,¹ and a new intermediate, purportedly from the tryptamine pathway for converting tryptophan to the main endogenous auxin, indole-3-acetic acid (IAA). Recently, however, we presented evidence challenging the original and subsequent identifications of the intermediate concerned.²Key words: auxin synthesis, YUCCA, tryptamine, N-hydroxytryptamineThe new gene was termed YUC, and the putative intermediate is N-hydroxytryptamine. It was claimed that the YUC protein, a flavin-containing monooxygenase, converts tryptamine (formed from tryptophan by decarboxylation) to N-hydroxytryptamine, which is converted via other intermediates to IAA. When the YUC gene was expressed in E. coli and the resulting protein incubated with tryptamine, a weak TLC spot resulted, which produced a mass spectrum said to match that expected from N-hydroxytryptamine.¹ However, the authors did not report mass spectral data from authentic N-hydroxytryptamine, and their suggested fragmentation pattern breaks a fundamental rule of mass spectrometry (the even-electron rule).² Nevertheless, N-hydroxytryptamine has been added to virtually all IAA synthesis schemes published since 2001.³In 2010, LeClere et al. expressed a maize YUC gene in E. coli,⁴ and again claimed that the resulting protein converted tryptamine to N-hydroxytryptamine. This time, the mass spectrum was of better quality, but we have shown that it does not match that of authentic N-hydroxytryptamine, synthesised in our laboratory.^2,5 We have demonstrated by electrospray tandem mass spectrometry that the protonated molecule of N-hydroxytryptamine (m/z 177) fragments to give an abundant ion at m/z 144. This was the crucial piece of evidence that the product obtained by LeClere et al. was not N-hydroxytryptamine, since their compound gave an abundant ion at m/z 160, and no ion at m/z 144.⁴The m/z 144 ion is formed by loss of NH₂OH (hydroxylamine), as shown by accurate mass determinations (Fig. 1). In other words, it is the alkyl-amine bond that is broken; this is also the case for tryptamine and serotonin. In the latter case, an m/z 160 ion results through loss of ammonia, because the hydroxyl group on the indole ring (at position 5) is retained in the fragment. The compound obtained by LeClere et al. when protonated, also had a mass of 177, consistent with a hydroxylated tryptamine, and the abundant m/z 160 ion indicates that this fragment, as in serotonin, retains the hydroxyl group.⁴ However, we believe that the LeClere et al. product is not serotonin, because of dissimilar behavior on thin layer chromatography. Apart from the probability that it is a hydroxylated tryptamine, the identity of the LeClere et al. product is not known.Open in a separate windowFigure 1Fragmentation of (A) N-hydroxytryptamine, (B) tryptamine and (C) 5-hydroxytryptamine (serotonin), as determined by MS/MS analysis.² The m/z ratios of the fragments produced are indicated. The loss of neutral hydroxylamine (A) or ammonia (B and C) involves heterolytic cleavage and/or hydrogen atom rearrangement, and consequent retention of the positive charge on the remaining indole-containing fragment.¹⁴It is interesting to contrast the previous “identifications” of N-hydroxytryptamine1,⁴ with the identification of gibberellins, during the period when most of the gibberellins were identified (1970–1990). There were rigorous criteria for the identification of these compounds, imposed by a triumvirate of “Gibberellin Godfathers”: Jake MacMillan, Nobatuka Takahashi and the late Bernard Phinney, and more latterly by Caporegimes such as Peter Hedden and Yuji Kamiya. Three of the present authors (James B. Reid, Noel W. Davies and John J. Ross) experienced at first hand the rigour with which these criteria were applied.Essentially, any identification of an endogenous gibberellin was viewed with suspicion unless a synthesized form of that compound (a standard, confirmed by NMR) was available for comparison. For a firm identification, the retention time on GC should be identical between the standard and the putative compound, on the same GC instrument. Next, the electron ionization fragmentation patterns of the compound of interest and the standard should match, again on the one GC-MS system. It was not considered adequate to compare a spectrum of the compound of interest with published spectra from another laboratory. Often a spectrum from a plant extract might contain extra ions, contributed by “interfering” compounds and this was sometimes acceptable. However, the absence of ions that should be present was usually sufficient to render the identification unconvincing. Electrospray mass spectra are intrinsically much poorer in information than electron ionisation spectra since most or all of the signal is concentrated in the protonated molecule, and tandem mass spectrometry (MS/MS) is required to create diagnostic fragment ions. The MS/MS spectrum of another hydroxylated tryptamine that we have examined is dominated by a strong m/z 160 ion, and discrimination between hydroxylated tryptamines on the basis of MS alone could be problematic. N-Hydroxytryptamine is the exception in this regard, and it can be easily distinguished.Another technique that has been used extensively in gibberellin research, and in early auxin research as well, is “feeding” labelled compounds and determining the fate of the label concerned (often deuterium or ¹³C). This technique contributed strongly to the identification of most of the candidate auxin pathways.⁶ Its power should not be underestimated, and yet in the auxin field, it was under-utilised during much of the later 1990s and the 2000s. We have used this technique to demonstrate that tryptamine is not converted to N-hydroxytryptamine in pea roots or seeds.^2,5 In fact, to our knowledge, N-hydroxytryptamine has not yet been identified in any plant species.N-Hydroxytryptamine has been the main link between the YUC genes and the tryptamine pathway, and this link is now called into question. In fact, there are some indications that YUCCAs might not be concerned with IAA synthesis at all. The floozy mutant of petunia has a strong phenotype but normal levels of IAA.⁷ The yuc1 yuc2 yuc4 yuc6 quadruple mutant of Arabidopsis also exhibits a whole-plant phenotype but again its IAA content is not reduced compared with WT plants.⁸ Indeed, as yet there is not a single instance where knocking out YUC function has been shown to significantly reduce IAA content. We should note also that while overexpression of YUC genes does lead to elevated IAA content, the increase is small (up to about 2-fold^1,9) compared with the increases recorded for other IAA over-producing mutants; for example, sur1 (also known as rty) and sur2, which can contain 5 to 20 times more IAA than the WT.¹⁰-12Therefore, it is possible that YUC catalyses a reaction or reactions in another pathway leading to another compound that is required for normal plant development; hence the phenotypic consequences of loss-of-function yuc mutants. This compound might be another auxin or auxinlike compound, which might explain why elevating auxin content genetically sometimes rescues yuc phenotypes.¹³ The suggestion that YUC controls the synthesis of another compound was made as early as 2002,⁷ but has attracted little attention from auxin biologists. There seems little doubt that YUCCAs play essential roles in plant development, as evidenced by the phenotypes of knockout mutants, even though it is sometimes necessary to construct multiple mutants to observe strong phenotypes.¹³ Furthermore, YUC genes are found in a wide range species, and we recently extended the list to include pea.² However, the almost universal placement of N-hydroxytryptamine in auxin synthesis schemes since 2001 is now called into question by the recently published evidence.²     

Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever

Background

Currently existing yellow fever (YF) vaccines are based on the live attenuated yellow fever virus 17D strain (YFV-17D). Although, a good safety profile was historically attributed to the 17D vaccine, serious adverse events have been reported, making the development of a safer, more modern vaccine desirable.

Methodology/Principal Findings

A gene encoding the precursor of the membrane and envelope (prME) protein of the YFV-17D strain was inserted into the non-replicating modified vaccinia virus Ankara and into the D4R-defective vaccinia virus. Candidate vaccines based on the recombinant vaccinia viruses were assessed for immunogenicity and protection in a mouse model and compared to the commercial YFV-17D vaccine. The recombinant live vaccines induced γ-interferon-secreting CD4- and functionally active CD8-T cells, and conferred full protection against lethal challenge already after a single low immunization dose of 10⁵ TCID₅₀. Surprisingly, pre-existing immunity against wild-type vaccinia virus did not negatively influence protection. Unlike the classical 17D vaccine, the vaccinia virus-based vaccines did not cause mortality following intracerebral administration in mice, demonstrating better safety profiles.

Conclusions/Significance

The non-replicating recombinant YF candidate live vaccines induced a broad immune response after single dose administration, were effective even in the presence of a pre-existing immunity against vaccinia virus and demonstrated an excellent safety profile in mice.